Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Activating Tgr5 may help treat hair loss and bone loss.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Baricitinib effectively promotes long-term hair regrowth in alopecia areata patients.

JAK inhibitors may help treat certain types of hair loss, but more research is needed.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Enz_MoriL from mulberry leaves helps hair growth by affecting specific cell pathways.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Upadacitinib effectively treats pyoderma gangrenosum.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Early treatment of Lupus Erythematosus Alopecia can prevent permanent hair loss, and various medications are effective.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

PDGFC gene may help select goats with desirable curly wool traits.